🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Biliary Disease

Vitamin D2 vs Vitamin D2 Plus Calcitriol in Cholestatic Children With Vitamin D Deficiency NCT07670611Phase 41 site📍 Bangkok Chulalongkorn University · Tests: Vitamin D2, Calcitriol Laser vs Electrohydraulic Lithotripsy for Difficult CBD Stones NCT07030829NA2 sites📍 Bangkok📍 Bangkok Mahidol University · Tests: Laser Lithotripsy, Electrohydraulic Lithotripsy Efficacy and Safety of Surgical Treatment for Type IVa CBD NCT07036848n/a1 site📍 Beijing Beijing Tsinghua Chang Gung Hospital CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US) NCT06193928n/a8 sites📍 Los Angeles📍 Aurora📍 Atlanta Mirum Pharmaceuticals, Inc. · Tests: Livmarli, Livmarli Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma NCT07780838Phase 21 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Cisplatin, Computed Tomography, Durvalumab, Gemcitabine Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE) NCT06277531n/a2 sites📍 Beijing📍 Beijing Peking University Third Hospital A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions NCT06864195n/a1 site📍 London Imperial College London Timing of CHolecystectomy In Severe PAncreatitis NCT06113419NA2 sites📍 Bogota📍 Bogota Hospital Universitario Mayor Méderi · Tests: Laparoscopic cholecystectomy Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients NCT07673861NA1 site📍 London Royal Marsden NHS Foundation Trust · Tests: Marsden360 ctDNA test and GTAB review A Prospective Study of Sacituzumab Tirumotecan Plus Pembrolizumab for Advanced Biliary Tract Cancer NCT07850791Phase 21 site📍 Beijing Haitao Zhao, MD · Tests: Sacituzumab Tirumotecan (SKB264), Pembrolizumab Nutritional Intervention for Biliary Atresia NCT06764082NA1 site📍 Wuhan Tongji Hospital · Tests: high MCT formula, normal oral intake of the traditional formula Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis NCT05751967Phase 37 sites📍 Lanzhou📍 Guangzhou📍 Nanjing Xijing Hospital of Digestive Diseases · Tests: Placebo Combined With Ursodeoxycholic Acid, Fenofibrate Combined With Ursodeoxycholic Acid Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study NCT07405086Phase 41 site📍 Portland OHSU Knight Cancer Institute · Tests: Biospecimen Collection, Immune Checkpoint Inhibitor The Treatment Effect for Asymptomatic Common Bile Duct Stone NCT06215040n/a1 site📍 Daegu Kyungpook National University Hospital · Tests: Endoscopic retrograde cholangiopancratography Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas NCT07155525NA1 site📍 Minya Minia University · Tests: Pancreaticojejunostomy with Modified N-Butyl-2-Cyanoacrylate (Glubran® 2), Standard(duct-to-mucosa) Pancreaticojejunost… Ligufalimab and Cadonilimab in Advanced Liver Cancers NCT06789848Phase 21 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Ligufalimab, Cadonilimab Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity NCT07463508NA1 site📍 Clermont-Ferrand University Hospital, Clermont-Ferrand · Tests: blood sampling, Tissue sampling Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer NCT07614061Phase 11 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: BTC-Ag-T (ACH-AgT001), Cyclophosphamide and Fludarabine Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy NCT07556913n/a1 site📍 Wilmington Ipsen · Tests: Elafibranor Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study NCT07051980Phase 21 site📍 Hangzhou Zhejiang University · Tests: Supraglottic Oxygen Delivery via an Endotracheal Tube Repeat Biliary Point of Care Ultrasound for Detecting Early Acute Cholecystitis NCT07792200NA1 site📍 York WellSpan Health · Tests: Repeat biliary point of care ultrasound Diagnostic Value of Deep Learning-Based Rapid MRI in Preoperative Evaluation of Acute Cholecystitis NCT07551375n/a1 site📍 Beijing Peking Union Medical College Hospital A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers NCT06611345NA1 site📍 Hefei Jiangsu Healthy Life Innovation Medical Technology Co., Ltd · Tests: Tumor Treating Fields, Durvalumab, Gemcitabine, Cisplatin Endoscopic Management of Non-anastomotic Biliary Strictures Following Liver Transplantation. NCT05761483n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: ERCP A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413Phase 123 sites📍 Goodyear📍 Phoenix📍 Duarte IDEAYA Biosciences · Tests: IDE892, IDE397 Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients NCT04753996n/a1 site📍 Rochester Mayo Clinic Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis NCT06781242n/a2 sites📍 Bologna📍 Modena IRCCS Azienda Ospedaliero-Universitaria di Bologna Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) NCT05482893Phase 1, Phase 211 sites📍 Duarte📍 Los Angeles📍 Denver Phanes Therapeutics · Tests: Spevatamig (PT886), Paclitaxel, Gemcitabine, Abraxane, KEYTRUDA® (pembrolizumab) Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer NCT06467357Phase 3272 sites📍 Scottsdale📍 Tucson📍 Tucson AstraZeneca · Tests: Gemcitabine, Cisplatin, Durvalumab, Trastuzumab deruxtecan, Rilvegostomig
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy